GBT
WST icon

Grove Bank & Trust’s West Pharmaceutical WST Stock Holding History

Grove Bank & Trust’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$718 Hold
2
– – ﹤0.01% 849
2026
Q1 		$501 Hold
2
– – ﹤0.01% 831
2025
Q4 		$550 Hold
2
– – ﹤0.01% 836
2025
Q3 		$525 Hold
2
– – ﹤0.01% 818
2025
Q2 		$438 Sell
2
-21
-91% -$4.49K ﹤0.01% 839
2025
Q1 		$5.15K Buy
23
+20
+667% +$5.51K ﹤0.01% 664
2024
Q4 		$983 Buy
3
+1
+50% +$315 ﹤0.01% 720
2024
Q3 		$600 Buy
+2
New +$612 ﹤0.01% 718

Other funds holding WST

RP
Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return
BHIA
Birch Hill Investment Advisors Boston, Massachusetts $2.47B AUM 20.95% 1-Year Est. Return
AAM
AMI Asset Management Los Angeles, California $1.74B AUM 26.89% 1-Year Est. Return
SIM
Seilern Investment Management London, United Kingdom $794M AUM 6.63% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
GWI
Grace & White Inc Ny, New York $632M AUM 34.34% 1-Year Est. Return
MCG
McCollum Christoferson Group Amherst, New York $341M AUM 15.01% 1-Year Est. Return
YCM
Yousif Capital Management Bloomfield Hills, Michigan $8.94B AUM 42.6% 1-Year Est. Return

Grove Bank & Trust's WST Position: Q2 2026 in Review

Grove Bank & Trust held its West Pharmaceutical (WST) position steady in Q2 2026 at 2 shares worth $718. The position accounts for ﹤0.01% of the portfolio, ranked #849.

Grove Bank & Trust first reported a position in WST in Q3 2024 and has held it in 8 quarters since. The position peaked at $5.15K in Q1 2025. 136 funds tracked by Wall St. Rank hold WST as of Q2 2026.

  • Grove Bank & Trust held 2 shares of West Pharmaceutical worth $718 as of Q2 2026.
  • Grove Bank & Trust left its West Pharmaceutical share count unchanged in Q2 2026.
  • West Pharmaceutical made up ﹤0.01% of Grove Bank & Trust's portfolio in Q2 2026, its #849 holding.
  • Grove Bank & Trust first reported a position in West Pharmaceutical in Q3 2024 and has held it in 8 quarters since.
  • Grove Bank & Trust's West Pharmaceutical position peaked at $5.15K in Q1 2025.
  • 136 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2026.

Based on Grove Bank & Trust's 13F filing for Q2 2026, filed 7 Jul 2026.